DOI: http://dx.doi.org/10.18203/2394-6040.ijcmph20163918

Seroprevalence of hepatitis B among pregnant women in Kigali, Rwanda

Mochama M. Nyamusi, Onesmus T. Marete, Wilson R. Waweru

Abstract


Background: Hepatitis B virus belongs to the family Hepadnaviridae. It is the commonest cause of chronic viral hepatitis. It is responsible for up to 80% of primary liver cancers. Despite the existence of a safe and effective vaccine, HBV infections still remain a global public health problem. Pregnant women who are carriers of the virus pose a significant risk to their unborn babies. Early diagnosis in this group can provide an avenue for prevention of mother to child transmission which will in turn lead to a reduction in the number of chronic carriers who act as a source of new infections.

Methods: The study was a multicenter, hospital based cross-sectional study. Data collection was using a questionnaire-guided interview followed by HBsAg determination using SD bioline test device. Data entry and statistical analysis was done using SPSS version 16. A p-value of less than 0.05 was considered significant.

Results: The prevalence of Hepatitis B among pregnant women in Kigali is 3.1%.The study findings also indicated that the mean age of the participants was 28.03 years with a standard deviation of 5.6 years. Majority of the women (37.4%) were between 25 and 29 years. About two thirds of the recruited women resided in urban area while a third was from rural area. Most of the women (61.3%) had attained primary level formal education with only a few with tertiary level education (7.9%). 6% of them had no formal education. Majority of these women (95%) were in marriage unions a majority of which were monogamous.   

Conclusions: The findings indicate an intermediate endemicity of HBV among the pregnant women in Kigali at 3.1% prevalence, the lowest among the East African countries. This is among the first Hepatitis B prevalence studies among the pregnant women, hence it provides baseline data that can be useful in contributing to knowledge of the disease characteristics, stimulate further research on the disease and also contribute to informing policy on control measures.

Keywords


Hepatitis B, Hepadnaviridae

Full Text:

PDF

References


Maynard E. Hepatitis B: global importance. Vaccine. 1990;8:S18-20.

Chowdhury D, Eapen CE. 2012: Perinatal transmission of Hepatitis B: Reviwe article Available at http://www.hepatitisbannual.org. Accessed on March 21,2012.

Nazan D. Congenital Hepatitis B Virus (HBV) Infection Review. J Ped Inf. 2007;1:63-7.

Kiire F. The epidemiology and prophylaxis of hepatitis B in sub-Saharan Africa: A view from tropical and subtropical Africa. Gut. 1996;38:S5-12.

Tse Y, Ho L, Lao T. The impact of maternal HBsAg carrier status on pregnancy outcomes: A case–control study. J Hepatolo. 2005; 43;771-5.

Lao T, Chan C, Leung W. Maternal hepatitis B infection and gestational diabetes mellitus. J Hepatology. 2007;47:46-50.

Okoth F, Mbuthia J, Gatheri Z Murila F, Kanyingi F, Mugo F, et al. Seroprevalence of Hepatitis B markers in Pregnant Women in Kenya. East Afr Med J. 2006;83(9):485-593.

MacLean B, Hess RF, Bonvillain E, Kamate J, Dao D, Cosimano A, et al. Seroprevalence of hepatitis B surface antigen among pregnant women attending the Hospital for Women & Children in Koutiala, Mali. S Afr Med J. 2012;102:47-9.

Elsheikh RM, Daak AA, Elsheikah MA. Hepatitis B virus and Hepatitis C virus in pregnant Sudanese women. Virol J. 2007;4:104.

Pellizzer G, Blè C, Zamperetti N, Stroffolini T, Upunda G, Rapicetta M, et al. Serological survey of hepatitis B infection in Tanzania. Public Health. 1994;108(6):427-31.

Pirillo F, Bassani L, Germinario P. Seroprevalence of hepatitis B and C viruses among HIV infected pregnant women in Uganda and Rwanda. J Med Virol. 2007;79:1797-801.

Eke C, Eke U, Okafor I, Ezebialu U, Ogbuagu C. Prevalence, correlates and pattern of hepatitis B surface antigen in a low resource setting. Virology Journal. 2011;8:12.

Mbamara SU, Obiechina. Seroprevalence and risk factors of hepatitis B Surface Antigen among antenatal clinic attendees in a private specialist hospital in Onitsha, Southeast Nigeria. Niger Med J. 2010;51(4):152-4.

Kew M. Progress towards the comprehensive control of hepatitis B in Africa: A view fro South Africa. Gut. 1996;38:S31-6.

Obi N, Onah E, Ezugwu O. Risk factors for Hepatitis B infection during pregnancy in a Nigerian population. Int J Obstetric Gynecolo. 2006;26(8):770-2.

Shamsuddin K, Marmuji LZ. 2010: Weighted analysis of prevalence and risk factors hepatitis B infection among antenatal mothers in Ipoh. Singapore Med J. 2010;51(10):800-5.

Dwivedi M, Misra S.P, Misra V, Pandey A, Pant S, Singh R, et al. Seroprevalence of hepatitis B infection during pregnancy and risk of perinatal transmission. Indian J Gastroenterol. 2011; 30(2):66-71.